Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
Meghna Jani, William G Dixon, Lianne Kersley-Fleet, Ian N Bruce, Hector Chinoy, Anne Barton, Mark Lunt, Kath Watson, BSRBR-RA*, BSRBR-RA Control Centre Consortium*, Deborah P Symmons, Kimme L Hyrich
RMD Open Jan 2017, 3 (1) e000314; DOI: 10.1136/rmdopen-2016-000314